US$ 21.37
ghk cu signaling molecule Molecular structure of the tripeptide GHK-Cu. In solution lysine Exploring the beneficial effects of
Description
Outcomes Co-primary endpoints were percentage change in body weight from baseline to week 104 and achievement of weight loss of at least 5% of baseline weight at week 104

Available: [10] K

Its classified as a Schedule 4 prescription-only medicine, making it illegal to possess without a valid prescription

EMBO J 2018;37:384-97
